Our founders, Dr. Markus Müschenich and Christian Lautner, launched the world’s first prescribable, fully-digital treatment for amblyopia reimbursed by public health insurance in 2014. They paved the way for Digital Drugs. Müschenich and Lautner’s goal throughout has been to leverage the strengths of science, practical medicine, and entrepreneurship.
A home for pioneers and leaders, Eternity.Health unites the new health industry’s leading companies under one roof. Over the past ten years, the holding addressed the determinants of health and innovations that drive relevant healthcare improvements. Alongside Ababax, the holding portfolio includes the consulting company and think tank, Flying Health, and the €100 million venture capital fund, Heal Capital.
Ababax’s lead investor is the Sana Hospital Group. Sana is the third-largest private hospital group in Germany and is owned by the 25 leading German private health insurance companies, including Allianz Insurance Group, DKV and Signal Iduna. It is an integrated healthcare delivery system with 54 hospitals and over 34.300 employees, serving more than 2.2 million patients annually.